Following the passage of GINA by US Congress, the Wall Street Journal reports that "a federal advisory panel called for tougher government oversight of the burgeoning genetic-testing business, warning that tests are being marketed with little evidence about their usefulness." (Now there's a shock.) The committee says all genetic lab tests should have to undergo stringent evaluation by FDA.